Bayer CropScience and Bion Tech settle patent infringement case in Korea
Bion Tech´s strain Y1336 produces agrastatin, which is covered by claims related to lipopeptides in Bayer CropScience’s patent portfolio. These lipopeptides contribute to the unique properties of Bayer’s Serenade products. The licence extends to various countries, with a focus on Asia. Financial terms of the settlement were not disclosed.
Mike Miille, head of business management Biologics at Bayer CropScience, commented: “Biologicals play a significant role in shaping farming´s future because they help to increase yield and optimise grower´s flexibility.” Bayer CropScience remains committed to investing in research and development to offer farmers worldwide integrated crop protection solutions combining seeds, chemical and biological crop protection products, as well as services and product stewardship measures. “Strong patent protection is the basis for this innovation,” Miille added.
Source: pharmabiz.com
